Silexon is Discovery Tools (Healthcare) in China that focus on design models business. Founded in 2018. They cover business area such as developer, AI-empower drug discovery technology, pharmaceutical company, AI technology, drug repositioning platform, macro-molecular design model, AI virtual molecule screening, pharmaceutical researcher, technical and AI-base datum analysis support.
2018
( 6 years old in 2024 )
Design Models
-
Room 317-321, 3/F, Building F7
No.9, Weidi Road, University City, Xianlin street, Qixia District
Nanjing, Jiangsu
China
Private
developerAI-empower drug discovery technologypharmaceutical companyAI technologydrug repositioning platformmacro-molecular design modelAI virtual molecule screeningpharmaceutical researchertechnical and AI-base datum analysis support
* We use standard office opening hours in near Silexon's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Silexon is Discovery Tools (Healthcare) business from China that founded in 2018 (6 years old in 2024), Silexon business is focusing on Design Models.
Silexon headquarter office and corporate office address is located in Room 317-321, 3/F, Building F7 No.9, Weidi Road, University City, Xianlin street, Qixia District Nanjing, Jiangsu China.
Silexon was founded in China.
In 2024, Silexon is currently focus on design models sector.
Above is snippet of Google Trends for "design models" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Silexon, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
